JYJing Ye

Jing Ye

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jing Ye has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Qing Luo

    The First Affiliated Hospital, Jiangxi Medical College, Nanchang University

    2 shared publications
  • Jun Wang

    Department of Otorhinolaryngology, Head and Neck Surgery, The First Affiliated Hospital, Jiangxi Medical College Nanchang University Nanchang China

    1 shared publication
  • Jun-Hao Tu

    Department of Otorhinolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, China

    1 shared publication
  • Li Shen

    Department of Otorhinolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, China

    1 shared publication
  • Li-Ping Luo

    Department of Otorhinolaryngology, Jiangxi Children's Hospital, Nanchang, China

    1 shared publication
  • Mei Han

    Department of Otorhinolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, China

    1 shared publication

Latest Publications

  • Human Neutrophil Elastase Induces Epithelial–Mesenchymal Transition via Autophagy in Chronic Rhinosinusitis with Nasal Polyps

    by Nongping Zhong, Yelong Bai, Wenxuan Zhu, Jing Ye, Qing Luo

    Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by significant tissue remodeling, in which Epithelial–mesenchymal transition (EMT) plays a pivotal role in this process. Autophagy, a cellular degradation mechanism crucial for maintaining cellular homeostasis, may also contribute to EMT in CRSwNP. Objectives: To investigate the role of autophagy in EMT during CRSwNP. Methods: Tissue specimens were obtained from control subjects and patients with CRSwNP. The expression levels of human neutrophil elastase (HNE), Transforming growth factor-β1 (TGF-β1), the autophagic protein LC3, and EMT-related markers (E-cadherin, N-cadherin, and vimentin) were detected using immunohistochemistry and Western blotting. The expression characteristics of TGF-β1 in CRSwNP and their relationship with autophagy caused by HNE was assessed by in-vitro culture of the human nasal epithelial cell line RPMI-2650 treated with human recombinant HNE. Results: Patients with CRSwNP had more protein expression of TGF-β1, LC3, N-cadherin, and vimentin, whereas the expression of E-cadherin was significantly decreased ( P < .05). Treatment of nasal epithelial cells with recombinant HNE also induced the upregulation of TGF-β1, LC3, N-cadherin and Vimentin, while reducing E-cadherin levels ( P < .05). Alternatively, treatment of nasal epithelial cells with an autophagy inhibitor or a TGF-β1 inhibitor mitigated EMT. Conclusion: HNE induced EMT by activating the autophagy in CRSwNP and TGF-β1 also played an important role in this process.


  • Protease-Activated Receptor-2 Decreased Zonula Occlidens-1 and Claudin-1 Expression and Induced Epithelial Barrier Dysfunction in Allergic Rhinitis

    by Jun Wang, Xue Kang, Zhi-Qun Huang, Li Shen, Qing Luo, Meng-Yue Li, Li-Ping Luo, Jun-Hao Tu, Mei Han, Jing Ye

    Protease-activated receptor-2 (PAR-2)-modulated tight junctions (TJs) have been suggested to be involved in the pathogenesis of chronic inflammatory diseases. However, immunopathogenesis remains to be investigated among patients with allergic rhinitis (AR). This study sought to investigate the role of PAR-2 in the modulation of epithelial barrier function and the expression of TJs in the nasal mucosa of AR patients. The expression of TJs and PAR-2 of the nasal mucosa in AR patients and control subjects by immunohistochemistry, quantitative real-time polymerase chain reaction (qRT-PCR), and western blotting. In vitro, Primary human nasal epithelial cells (pHNECs) of AR patients were stimulated by Der p1 to analyze the correlation between PAR-2 and TJs expression. Der p1-induced pHNECs were treated with the PAR-2 agonist SLIGRL-NH2 and antagonist FSLLRY-NH2. Fluorescein isothiocyanate–dextran 4 kDa detection was employed as an indicator of epithelial permeability. Lower expression levels of TJs in the nasal epithelium of AR patients were observed in comparison with that in control subjects. The PAR-2 level was markedly increased following treatment with 1,000 ng/mL of Der p1 for 24 hours in a cellular model of AR. The expression of PAR-2 was increased in Der p1-induced pHNECs of AR patients and correlated inversely with zonula occlidens (ZO)-1 and claudin-1. Treatment with Der p1 further downregulated TJs expression and promoted an increased epithelial permeability in Der p1-induced pHNECs. PAR-2 could downregulate the expression of ZO-1 and claudin-1, which is involved in epithelial barrier dysfunction in AR.